Juvaris is pleased to work with the following collaborators:

 Steve Dow, Ph.D., DVM, Colorado State University, is collaborating with the company on various issues ranging from examination of the mechanisms of immunity elicited by JuvaVax complexes and how the immune profile varies with route of administration to the examination of new product opportunities in asthma and allergy.

 David Claxton, M.D., Penn State University, is collaborating with the company to develop immunotherapeutic treatments for human cancers. Specifically, the current focus is the development of a treatment for Acute Myelogenous Leukemia. Dr. Claxton and the company have an SBIR grant for this project currently under review.

 Dave Lewis, M.D., Stanford University, is collaborating with the company to develop infectious disease immunotherapeutic treatments. Dr. Lewis s interests involve cytomegalovirus and influenza.